BioInformatics’ Danyi Wu, Ph.D., reveals how 748 life scientists rated 28 suppliers in 2026: New England Biolabs at #1, BD Biosciences up from #26 to #2, and supplier AI use.

Free Kalorama white paper: the IVD market reached $115.6 billion in 2025 and heads to $150.4 billion by 2030. See which segments, regions and companies drive growth.

The FDA has exempted Class II clinical toxicology systems from 510(k) premarket notification, opening the door for oral fluid and hair drug testing in federal workplace programs including DOT.

Kalorama analysts break down The Worldwide Market for IVD Tests, 19th Edition: $115.6 billion in 2025, forecasts to 2030, segments, regions and competitive trends. Free and on demand.

Clinical laboratories rarely make headlines, yet they’re involved in most medical decisions. Diagnosing disease, selecting treatments, monitoring patients, and detecting recurrence all depend on laboratory testing. The work happens largely behind the scenes, which is…